Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma

BACKGROUND: IDH-mutant lower-grade gliomas (LGGs) evolve under the selective pressure of therapy, but well-characterized patient-derived cells (PDCs) modeling evolutionary stages are lacking. IDH-mutant LGGs may develop therapeutic resistance associated with chemotherapy-driven hypermutation and mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Lindsey E, Hilz, Stephanie, Grimmer, Matthew R, Mazor, Tali, Najac, Chloé, Mukherjee, Joydeep, McKinney, Andrew, Chow, Tracy, Pieper, Russell O, Ronen, Sabrina M, Chang, Susan M, Phillips, Joanna J, Costello, Joseph F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462278/
https://www.ncbi.nlm.nih.gov/pubmed/32904945
http://dx.doi.org/10.1093/noajnl/vdaa088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462278/
https://www.ncbi.nlm.nih.gov/pubmed/32904945
http://dx.doi.org/10.1093/noajnl/vdaa088

Ejemplares similares